성기단순포진의 권고치료

키워드

참고문헌 (30)

1. Fatahzadeh M, "Human herpes simplex virus infections : epidemiology, pathogenesis, symptomatology, diagnosis, and management", J Am Acad Dermatol, 57, pp.737~763 (2007)
2. Xu F, "Trends in herpes simplex virus type 1 and type 2seroprevalence in the United States", JAMA, 296, pp.964~973 (2006)
3. Lee CB, "Epidemiological characteristics of genital herpes and condyloma acuminata in patients presenting to urologic and gynecologic clinics in Korea", J Infect Chemother, 17, pp.351~357 (2011)
4. Katz AR, "Sexually transmitted disease(STD)update : a review of the CDC 2010 STD treatment guidelines and epidemiologic trends of common STDs in Hawai'i", Hawaii J Med Public Health, 71, pp.68~73 (2012)
5. Patel R, "European guideline for the management of genital herpes, 2010", Int J STD AIDS, 22, pp.1~10 (2011)
6. Workowski KA, "Sexually transmitted disease treatment guidelines", MMWR Recomm Rep, 59, pp.20~25 (2010)
7. Corey L, "Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy", J Antimicrob Chemother, 12(Suppl B), pp.79~88 (1983)
8. Fife KH, "Results of an international, multicenter, double-blind, randomized clinical trial", Sex Transm Dis, 24, pp.481~486 (1997)
9. Reyes M, "Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics", Arch Intern Med, 163, pp.76~80 (2003)
10. Martin JM, "Update on the treatment of genital herpes", Actas Dermosifiliogr, 100, pp.22~32 (2009)
11. Korea Centers for Disease Control and Prevention, "Sexually transmitted infections Korean guidelines", Korea Centers for Disease Control and Prevention, Korean Association of Urogenital Tract Infection and Inflammation, ~ (2011)
12. Weightman W, "Allergic contact dermatitis from lignocaine:report of 29 cases and review of the literature", Contact Dermatitis, 39, pp.265~266 (1998)
13. Nilsen AE, "Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes", Lancet, 2, pp.571~573 (1982)
14. Sacks SL, "Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial", JAMA, 276, pp.44~49 (1996)
15. Spruance SL, "A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis", Arch Intern Med, 156, pp.1729~1735 (1996)
16. Spruance SL, "The natural history of recurrent herpes simplex labialis:implications for antiviral therapy", N Engl J Med, 297, pp.69~75 (1977)
17. Mertz GJ, "Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled tria", Arch Intern Med, 157, pp.343~349 (1997)
18. Diaz-Mitoma F, "Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial", JAMA, 280, pp.887~892 (1998)
19. Reitano M, "Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study", J Infect Dis, 178, pp.603~610 (1998)
20. Romanowski B, "Valtrex HS230017Study Group. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study", Sex Transm Dis, 30, pp.226~231 (2003)
21. Goldberg LH, "Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark", Arch Dermatol, 129, pp.582~587 (1993)
22. Fife KH, "Recurrence and resistance patterns of herpes simplex virus following cessation of ＞ or = 6 years of chronic suppression with acyclovir", J Infect Dis, 169, pp.1338~1341 (1994)
23. Mindel A, "Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes", Lancet, 1, pp.926~928 (1988)
24. Lebrun-Vignes B, "A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks", J Am Acad Dermatol, 57, pp.238~246 (2007)
25. Geretti AM, "Genital herpes", Sex Transm Infect, 82(Suppl 4), pp.iv31~iv34 (2006)
26. Corey L, "Once-daily valacyclovir to reduce the risk of transmission of genital herpes", N Engl J Med, 350, pp.11~20 (2004)
27. Erard V, "Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease", J Infect Dis, 196, pp.266~270 (2007)
28. Kaliaperumal K, "Recent advances in management of genital ulcer disease and anogenital warts", Dermatol Ther, 21, pp.196~204 (2008)
29. Bernstein DI, "Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine", Clin Infect Dis, 40, pp.1271~1281 (2005)
30. Rajcani J, "Developments in herpes simplex virus vaccines: old problems and new challenges", Folia Microbiol(Praha), 51, pp.67~85 (2006)

관련 논문AI추천